Sweta Dash

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “The SRC family kinase inhibitor NXP900 demonstrates potent antitumor activity in squamous cell carcinomas”.

The SRC family kinase inhibitor NXP900 demonstrates potent antitumor activity in squamous cell carcinomas

Journal of Biological Chemistry(2024)10.1016/j.jbc.2024.107615

N/A

0.377DataRank · unranked

8 citations

Sabrina Hanson, Ben King, Katherine M. Nyswaner, Kelcie Foss, Noelle Tesi +8 more

Effects of long-term norepinephrine treatment on normal immortalized ovarian and fallopian tube cells

Scientific Reports(2021)10.1038/s41598-021-93506-z

N/A

0DataRank · unranked

5 citations

Sean J. Yoder, Tania Mesa, Andrew T. Smith, Ling Cen, Steven A. Eschrich +3 more

Integrated proteomics identifies PARP inhibitor-induced prosurvival signaling changes as potential vulnerabilities in ovarian cancer

Journal of Biological Chemistry(2022)10.1016/j.jbc.2022.102550

N/A

0DataRank · unranked

5 citations

Sweta Dash, Thales C. Nepomuceno, Bin Fang, Sang Y. Yun, Eric A. Welsh +6 more

Targeting c-MYC and gain-of-function p53 through inhibition or degradation of the kinase LZK suppresses the growth of HNSCC tumors

Science Signaling(2025)10.1126/scisignal.ado2857

N/A

0DataRank · unranked

9 citations

Meghri Katerji, Marwa M. Afifi, Katherine M. Nyswaner, Carolyn C. Woodroofe, Zoe C. Edwards +22 more